MLL: How complex does it get?

被引:71
作者
Popovic, R
Zeleznik-Le, NJ
机构
[1] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Mol Oncol Program,Dept Med, Maywood, IL 60153 USA
[2] Loyola Univ, Med Ctr, Program Mol Biol, Maywood, IL 60153 USA
关键词
MLL; leukemia;
D O I
10.1002/jcb.20430
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The mixed lineage leukemia (MLL) gene encodes a very large nuclear protein homologous to Drosophila trithorax (trx). MLL is required for the proper maintenance of HOX gene expression during development and hematopoiesis. The exact regulatory mechanism of HOX gene expression by MLL is poorly understood, but it is believed that MLL functions at the level of chromatin organization. MLL was identified as a common target of chromosomal translocations associated with human acute leukemias. About 50 different MLL fusion partners have been isolated to date, and while similarities exist between groups of partners, there exists no unifying property shared by all the partners. MLL gene rearrangements are found in leukemias with both lymphoid and myeloid phenotypes and are often associated with infant and secondary leukemias. The immature phenotype of the leukemic blasts Suggests an important role for MLL in the early stages of hematopoietic development. M//homozygous mutant mice are embryonic lethal and exibit deficiencies in yolk sac hematopoiesis. Recently, two different MLL-containing protein complexes have been isolated. These and other gain- and loss-of-function experiments have provided insight into normal MLL function and altered functions of MLL fusion proteins. This article reviews the progress made toward understanding the function of the wild-type MILL protein. While many advances in understanding this multifaceted protein have been made since its discovery, many challenging questions remain to be answered. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 49 条
[1]   THE PHD FINGER - IMPLICATIONS FOR CHROMATIN-MEDIATED TRANSCRIPTIONAL REGULATION [J].
AASLAND, R ;
GIBSON, TJ ;
STEWART, AF .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (02) :56-59
[2]  
Adler HT, 1999, MOL CELL BIOL, V19, P7050
[3]   HRX leukemic fusion proteins form a heterocomplex with the leukemia-associated protein SET and protein phosphatase 2A [J].
Adler, HT ;
Nallaseth, FS ;
Walter, G ;
Tkachuk, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28407-28414
[4]   NuRD and SIN3 - histone deacetylase complexes in development [J].
Ahringer, J .
TRENDS IN GENETICS, 2000, 16 (08) :351-356
[5]   Transformation of myeloid progenitors by MLL oncoproteins is dependent on Hoxa7 and Hoxa9 [J].
Ayton, PM ;
Cleary, ML .
GENES & DEVELOPMENT, 2003, 17 (18) :2298-2307
[6]   Molecular mechanisms of leukemogenesis mediated by MLL fusion proteins [J].
Ayton, PM ;
Cleary, ML .
ONCOGENE, 2001, 20 (40) :5695-5707
[7]   The MT domain of the proto-oncoprotein MLL binds to CpG-containing DNA and discriminates against methylation [J].
Birke, M ;
Schreiner, S ;
García-Cuéllar, MP ;
Mahr, K ;
Titgemeyer, F ;
Slany, RK .
NUCLEIC ACIDS RESEARCH, 2002, 30 (04) :958-965
[8]   Positional cloning of the gene for multiple endocrine neoplasia-type 1 [J].
Chandrasekharappa, SC ;
Guru, SC ;
Manickam, P ;
Olufemi, SE ;
Collins, FS ;
EmmertBuck, MR ;
Debelenko, LV ;
Zhuang, ZP ;
Lubensky, IA ;
Liotta, LA ;
Crabtree, JS ;
Wang, YP ;
Roe, BA ;
Weisemann, J ;
Boguski, MS ;
Agarwal, SK ;
Kester, MB ;
Kim, YS ;
Heppner, C ;
Dong, QH ;
Spiegel, AM ;
Burns, AL ;
Marx, SJ .
SCIENCE, 1997, 276 (5311) :404-407
[9]   An MII-AF9 fusion gene made by homologous recombination causes acute leukemia in chimeric mice: A method to create fusion oncogenes [J].
Corral, J ;
Lavenir, I ;
Impey, H ;
Warren, AJ ;
Forster, A ;
Larson, TA ;
Bell, S ;
McKenzie, ANJ ;
King, G ;
Rabbitts, TH .
CELL, 1996, 85 (06) :853-861
[10]   Structure and ligand of a histone acetyltransferase bromodomain [J].
Dhalluin, C ;
Carlson, JE ;
Zeng, L ;
He, C ;
Aggarwal, AK ;
Zhou, MM .
NATURE, 1999, 399 (6735) :491-496